Reuters logo
3 months ago
BRIEF-International Stem Cell receives approval to start second patient cohort in clinical trial for Parkinson’s disease
May 9, 2017 / 12:38 PM / 3 months ago

BRIEF-International Stem Cell receives approval to start second patient cohort in clinical trial for Parkinson’s disease

May 9 (Reuters) - International Stem Cell Corp:

* International Stem Cell Corporation receives approval to start second patient cohort in clinical trial for parkinson’s disease

* International Stem Cell Corp - DSMB has authorized clinical trial to move forward with accelerated enrollment and dose escalation to second cohort Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below